Cleared Traditional

K250370 - SCENARIA View Phase 5.0

K250370 is the FDA 510(k) clearance for SCENARIA View Phase 5.0 by Fujifilm Corporation. It is a Class 2 Radiology device (product code JAK) cleared through the Traditional 510(k) pathway after a 99-day FDA review.

K250370 · Fujifilm Corporation · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2025
Decision
99d
Days
Class 2
Risk

K250370 is an FDA 510(k) clearance for the SCENARIA View Phase 5.0. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Fujifilm Corporation (Minato-Ku, JP). The FDA issued a Cleared decision on May 20, 2025 after a review of 99 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fujifilm Corporation devices

Submission Details

510(k) Number K250370 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 10, 2025
Decision Date May 20, 2025
Days to Decision 99 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 107d · This submission: 99d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

FUJIFILM Healthcare Americas Corporation
Chaitrali Kulkarni

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 581
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K250370.
Philips iCT CT system
K250648 · Philips Medical Systems Nederland B.V. · Jun 2025
CT Scanner TSX-501R/1 V11.1
K243398 · Canon Medical Systems Corporation · Jun 2025
CardIQ Suite
K243672 · GE Medical Systems SCS · Jun 2025
uCT ATLAS Astound with uWS-CT-Dual Energy Analysis
K243617 · Shanghai United Imaging Healthcare Co., Ltd. · May 2025
Spectral CT
K244008 · Philips Medical Systems Technologies , Ltd. · May 2025
SpotLight / SpotLight Duo with Low Dose Lung Cancer Screening Option
K250650 · Arineta , Ltd. · Apr 2025